BCL11A and non-small cell lung carcinoma: The multivariate survival analysis indicated that BCL11A expression level was an independent marker of DFS in patients with NSCLC (hazards ratio [HR] 0.40, 95% confidence interval [CI] 0.22–0.72, P = 0.002).